Prophylaxis and treatment of neoplastic meningeosis in childhood acute lymphoblastic leukemia

Journal of Neuro-Oncology

Volumn 38, Issue 2-3, 1998, Pages 159-165

  Schrappe, Martin ^a   Reiter, Alfred ^a   Riehm, Hansjörg ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acute lymphoblastic leukemia; CNS prophylaxis; Meningeosis

Indexed keywords

METHOTREXATE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; INTRATHECAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; NEOPLASTIC MENINGOSIS; SURVIVAL TIME; TREATMENT OUTCOME;

ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; HUMANS; INCIDENCE; INJECTIONS, SPINAL; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIC INFILTRATION; MENINGES; METHOTREXATE; RECURRENCE;

EID: 0031798867     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005903414734     Document Type: Conference Paper

References (21)

1. Mastrangelo R, Poplack DG, Bleyer WA, Riccardi R, Sather H, D'Angio GJ: Report and recommendations of the Rome Workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Med Pediatr Oncol 14: 191-194, 1986
2. Mahmoud HH, Rivera GK, Hancock ML, Krance RA, Kun LE, Behm FG, Ribeiro RC, Sandlund JT, Crist WM, Pui CH: Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia. New Eng J Med 329: 314-319, 1993
3. van der Does van den Berg A, Bartram CR, Basso G, Benoit YC, Biondi A, Debatin KM, Haas OA, Harbott J, Kamps WA, Koller U, Lampert F, Ludwig W-D, Niemeyer CM, van Wering ER: Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the 'BFM Family' Cooperative Group. Med Pediatr Oncol 20: 497-505, 1992
4. Reiter A, Schrappe M, Ludwig W-D, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Odenwald E, Ritter J, Mann G, Welte K, Gadner H, Riehm H: Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84: 3122-3133, 1994
5. Creutzig U, Ritter J, Riehm H, Langermann H-J, Henze G, Kabisch H, Niethammer D, Jürgens H, Stollmann B, Lasson U, Kaufmann U, Löffler H, Schellong G: Improved treatment results in childhood acute myelogeneous leukemia: a report of the German cooperative study AML-BFM-78. Blood 65: 298-304, 1985
6. Gilchrist GS, Tubergen DG, Sather HN, Coccia PF, O 'Brien RT, Waskerwitz MJ, Hammond GD: Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report. J Clin Oncol 12: 2594-2600, 1994
7. Lauer SJ, Kirchner PA, Camitta BM: Identification of leukemic cells in the cerebrospinal fluid from children with acute lymphoblastic leukemia: advances and dilemmas. Am J Pediatr Hematol Oncol 11: 64-73, 1989
8. Langermann H-J, Henze G, Wulf M, Riehm H: Abschätzung der Tumorzellmasse bei der akuten lymphoblastischen Leukämic im Kindesalter: prognostische Bedeutung und praktische Anwendung. Klin Pädiatr 194: 209-213, 1982
9. Schrappe M, Reiter A, Sauter S, Ludwig W-D, Wörmann B, Harbott J, Bender-Götze C, Dörffel W, Dopfer R, Frey E, Havers W, Henze G, Kühl J, Richter R, Ritter J, Treuner J, Zintl F, Odenwald E, Welte K, Riehm H: Konzeption und Zwischenergebnis der Therapiestudie ALL-BFM 90 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: Die Bedeutung des initialen Therapieansprechens in Blut und Knochenmark [Concept and interim analysis of trial ALL-BFM 90 for the treatment of children and adolescents with acute lymphoblastic leukemia: significance of therapy response in peripheral blood and bone marrow]. Klin Pädiatr 206: 208-221, 1994
10. Riehm H, Reiter A, Schrappe M, Berthold F, Dopfer R, Gerein H, Ludwig R, Ritter J, Stollmann B, Henze G: Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämic im Kindesalter (Therapiestudie ALL-BFM 83) [The in vivo response on corticosteroid therapy as an additional prognostic factor in childhood acute lymphoblastic leukemia (therapy study ALL-BFM 83)]. Klin Pädiatr 199: 151-160, 1987
11. Riehm H, Gadner H, Henze G, Kornhuber B, Lampert F, Niethammer D, Reiter A, Schellong G: Results and significance of six randomized trials in four consecutive ALL-BFM trials. Haematol Blood Transfus 33: 439-450, 1990
12. Schrappe M, Beck J, Brandeis WE, Feickert HJ, Gadner H, Graf N, Havers W, Henze G, Jobke A, Kornhuber B, Kühl J, Lampert F, Müller-Weihrich S, Niethammer D, Reiter A, Rister M, Ritter J, Schellong G, Tausch W, Weinel P, Riehm H: Die Behandlung der akuten lymphoblastischen Leukämie im Kindes-und Jugendalter: Ergebnisse der multizentrischen Therapiestudie ALL-BFM 81. Klin Pädiatr 199: 133-150, 1987
13. Conter V, Schrappe M, Arico M, Reiter A, Rizarri C, Dördelmann M, Valsecchi MG, Zimmermann M, Ludwig W-D, Basso G, Masera G, Riehm H: The role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. J Clin Oncol 15: 2786-2791, 1997
14. Reiter A, Schrappe M, Ludwig WD, Lampert F, Harbott J, Henze G, Niemeyer CM, Gadner H, Muller-Weihrich S, Ritter J, Odenwald E, Riehm H: Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood 80: 2471-2478, 1992
15. Gelber RD, Sallan SE, Cohen HJ, Donnelly M, Dalton V, Tobia F, Clavell LA, Tarbell NJ: Central nervous system treatment in childhood acute lymphoblastic leukemia. Long-term follow-up of patients diagnosed between 1973 and 1985. Cancer 72: 261-270, 1993
16. Dorffel W, Zintl F, Malke H, Reuter G, Reimann M: Prognosis of initial CNS involvement in acute lymphoblastic leukemia childhood. Haematol Blood Transfus 33: 494-499, 1990
17. Conter V, Arico M, Valsecchi MG, Rizzari C, Testi AM, Messina C, Mori PG, Miniero R, Colella R, Basso G, Rondelli R, Pession A, Masera G, for the Associazione Italiana di Ematologia ed Oncologia Pediatrica: Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munster-based intensive chemotherapy. J Clin Oncol 13: 2497-2502, 1995
18. Tubergen DG, Gilchrist GS, O'Brien RT, Coccia PF, Sather HN, Waskerwitz MJ, Hammond GD: Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report. J Clin Oncol 11: 520-526, 1993
19. Creutzig U, Ritter J, Zimmermann M, Schellong G: Does cranial irradiation reduce the risk for bone marrow relapse an acute myelogenous leukemia? Unexpected results of the childhood acute myelogenous leukemia study BFM-87. J Clin Oncol 11: 279-286, 1993
20. Odom LF, Wilson H, Cullen J, Bank J, Blake M, Jamieson B: Significance of blasts in low-cell-count cerebrospinal fluid specimens from children with acute lymphoblastic leukemia. Cancer 66: 1748-1754, 1990
21. Tubergen DG, Cullen JW, Boyett JM, Gilchrist GS, O'Brien RT, Coccia PF, Waskerwitz MJ: Blasts in CSF with a normal cell count do not justify alteration of therapy for acute lymphoblastic leukemia in remission: a Childrens Cancer Group Study. J Clin Oncol 12: 273-278, 1994